跳至主要内容
临床试验/NCT05673564
NCT05673564已完成不适用

Anatomical Resection in Colorectal Liver Metastases Patients

Fudan University0 个研究点目标入组 729 人开始时间: 2012年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
729
主要终点
RFS

研究概览

简要总结

The type of liver resection (anatomical resection, AR or nonanatomical resection, NAR) for colorectal liver metastases (CRLM) is subject to debate. The debate may persist because some certain prognostic factors, associated with aggressive biological behavior of tumor, have been overlooked. The aim of our study was to investigate the characteristics of patients who would benefit more from anatomical resection for colorectal liver metastases.

详细描述

729 patients who underwent hepatic resection of CRLM were retrospectively collected from June 2012and May 2019. Treatment effects between AR and NAR were compared in full subgroup analyses. Tumor relapse-free survival (RFS) was evaluated by a stratified log-rank test and summarized with the use of Kaplan-Meier and Cox proportional hazards methods.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1)Age 18-79 years;(2) Histologically proven colorectal adenocarcinoma;

排除标准

  • (1) the histologic type of tumor was not called adenocarcinoma; (2) peritoneal metastasis; (3) number of liver metastasis >3; (4) simultaneous anatomical and nonanatomical resections; (5) R2 resection; (6) history of previous hepatectomy; (7) incomplete data. The rest of patients were divided into 2 groups: patients undergoing an AR, and patients undergoing a NAR.

结局指标

主要结局

RFS

时间窗: 2012.6.1-2022.6.1

Relapse-free survival since patients undergoing hepatic resection

次要结局

  • OS(2012.6.1-2022.6.1)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu jianmin

Head of Colorectal Surgery

Fudan University

相似试验